New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 22, 2014
10:29 EDTNSR, VJET, SHLD, QIWI, DTV, JCP, WUBA, WWE, ITMN, IBNOptions with decreasing implied volatility
Options with decreasing implied volatility: NSR ITMN WWE WUBA JCP DTV QIWI SHLD VJET IBN
News For NSR;ITMN;WWE;WUBA;JCP;DTV;QIWI;SHLD;VJET;IBN From The Last 14 Days
Check below for free stories on NSR;ITMN;WWE;WUBA;JCP;DTV;QIWI;SHLD;VJET;IBN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2014
16:18 EDTNSRNeuStar backs FY14 adjusted EPS view of $3.88-$4.05, consensus $3.74
Reaffirms FY14 revenue $945M-$970M, consensus $956.58M.
16:17 EDTNSRNeuStar reports Q2 adjusted EPS 95c, consensus 90c
Reports Q2 revenue $237.5M, consensus $233.05M.
July 22, 2014
10:00 EDTQIWIOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Abengoa Yield (ABY) initiated with an Equal Weight at Morgan Stanley... Actinium Pharmaceuticals (ATNM) initiated with a Buy at Canaccord... Axys Technologies (AXYS) initiated with a Buy at Dougherty... Chambers Street Properties (CSG) initiated with a Neutral at SunTrust... Enphase Energy (ENPH) initiated with a Buy at Dougherty... Minerals Technologies (MTX) initiated with an Outperform at Wedbush... NextEra Energy Partners (NEP) initiated with a Buy at BofA/Merrill... PTC Therapeutics (PTCT) initiated with a Buy at BofA/Merrill... QIWI (QIWI) initiated with a Positive at Susquehanna... Quality Systems (QSII) initiated with a Buy at Topeka... Sarepta (SRPT) initiated with a Neutral at BofA/Merrill... Trinseo S.A. (TSE) initiated with a Buy at BofA/Merrill... Washington Prime Group (WPG) initiated with a Neutral at SunTrust... Zhaopin (ZPIN) initiated with a Buy at UBS.
06:37 EDTVJETPiper recommends buying 3D space following pullback
Piper Jaffray recommends using the recent weakness in shares of 3D printing companies as a buying opportunity, saying its Q2 reseller/industry survey yielded favorable feedback. The firm has Overweight ratings on 3D Systems (DDD), Materialise (MTLS), Materialise (MTLS), Proto Labs (PRLB) and Stratasys (SSYS). It has a Neutral rating on Voxeljet (VJET).
July 21, 2014
19:21 EDTQIWIQIWI initiated with a Positive at Susquehanna
Subscribe for More Information
11:19 EDTITMNInterMune July weekly volatility elevated
Subscribe for More Information
July 18, 2014
10:40 EDTJCPJ.C. Penney call active on renewed takeover chatter
Subscribe for More Information
10:28 EDTJCPRumor: J.C. Penney moves up on renewed takeover chatter
July 17, 2014
12:42 EDTITMNInterMune receives FDA Breakthrough Therapy Designation for pirfenidone
InterMune announced that pirfenidone has been granted Breakthrough Therapy Designation from the U.S. FDA. This designation is reserved for drugs that are intended to treat a serious or life threatening disease or condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints. Pirfenidone is an investigational treatment for adult patients with idiopathic pulmonary fibrosis.
July 15, 2014
07:08 EDTQIWIQIWI price target raised to $62 from $50 at JPMorgan
Subscribe for More Information
July 14, 2014
09:33 EDTQIWIQIWI initiated with a Buy at Deutsche Bank
Target $60.
July 13, 2014
15:18 EDTJCPJ.C. Penney CEO successor search faces setback, WSJ says
It appears that J.C. Penney (JCP) is not having an easy time of identifying a successor for current CEO Myron Ullman, says the Wall Street Journal. According to the WSJ report, Mindy Grossman, CEO of HSN (HSNI), who is considered the lead candidate for Ullman's position, had been in talks with J.C. Penney but could not agree on terms and negotiations broke down moths ago. Reference Link
July 10, 2014
13:40 EDTDTVVerizon CEO calls Q2 'strong,' says not interested in satellite company
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use